Dr. Agarwal's Eye Hospital Limited (BOM:526783)
India · Delayed Price · Currency is INR 5,373.85
+63.85 (1.20%)
At close: Aug 21, 2026
BOM:526783 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 4,969 | 4,709 | 3,972 | 3,193 | 2,681 | 2,012 |
| 4,969 | 4,709 | 3,972 | 3,193 | 2,681 | 2,012 | |
Revenue Growth | 20.01% | 18.56% | 24.38% | 19.10% | 33.24% | 43.39% |
Cost of Revenue | 2,682 | 2,593 | 2,260 | 1,868 | 1,576 | 649.3 |
Gross Profit | 2,288 | 2,116 | 1,712 | 1,325 | 1,105 | 1,363 |
Selling, General & Admin | - | 204.5 | 147.8 | 127.7 | 106.3 | 71.2 |
Other Operating Expenses | 773.2 | 451.7 | 370.4 | 282.4 | 246.1 | 714.8 |
Operating Expenses | 1,239 | 1,119 | 919.9 | 678.3 | 556.5 | 989.9 |
Operating Income | 1,049 | 996.7 | 792.1 | 646.8 | 548.3 | 372.9 |
Interest Expense | -105 | -118.3 | -123.6 | -71 | -68 | -61.2 |
Interest & Investment Income | - | 16.9 | 8.2 | 19.5 | 7.8 | 5.4 |
Currency Exchange Gain (Loss) | - | - | - | - | -1.1 | -0.1 |
Other Non Operating Income (Expenses) | 69.9 | 9 | 5.7 | 12.3 | 4.3 | 3.9 |
EBT Excluding Unusual Items | 1,014 | 904.3 | 682.4 | 607.6 | 491.3 | 320.9 |
Gain (Loss) on Sale of Investments | - | 27.7 | 8.8 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | -1.6 | -2.3 | 0.3 | 2.2 |
Other Unusual Items | - | 4.1 | 17.4 | 17.2 | 2.4 | - |
Pretax Income | 1,014 | 936.1 | 707 | 622.5 | 494 | 323.1 |
Income Tax Expense | 251.6 | 235.1 | 160.5 | 158.9 | 124.8 | 82.1 |
Net Income | 762.2 | 701 | 546.5 | 463.6 | 369.2 | 241 |
Net Income to Common | 762.2 | 701 | 546.5 | 463.6 | 369.2 | 241 |
Net Income Growth | 31.87% | 28.27% | 17.88% | 25.57% | 53.20% | - |
Shares Outstanding (Basic) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Outstanding (Diluted) | 5 | 5 | 5 | 5 | 5 | 5 |
Shares Change | 2.15% | 1.45% | - | - | - | - |
EPS (Basic) | 158.76 | 147.02 | 116.28 | 98.64 | 78.55 | 51.28 |
EPS (Diluted) | 158.76 | 147.02 | 116.28 | 98.64 | 78.55 | 51.28 |
EPS Growth | 29.09% | 26.44% | 17.88% | 25.57% | 53.19% | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | - | 467.5 | -93 | 184.5 | -7.2 | 99.5 |
Free Cash Flow Per Share | - | 98.05 | -19.79 | 39.26 | -1.53 | 21.17 |
Dividend Per Share | - | 7.000 | 6.000 | 5.000 | 3.000 | 3.000 |
Dividend Growth | - | 16.67% | 20.00% | 66.67% | 0% | - |
Gross Margin | 46.04% | 44.94% | 43.11% | 41.50% | 41.21% | 67.73% |
Operating Margin | 21.11% | 21.17% | 19.95% | 20.26% | 20.45% | 18.53% |
Profit Margin | 15.34% | 14.89% | 13.76% | 14.52% | 13.77% | 11.98% |
Free Cash Flow Margin | - | 9.93% | -2.34% | 5.78% | -0.27% | 4.95% |
EBITDA | 1,562 | 1,262 | 1,020 | 779.5 | 643.8 | 489 |
EBITDA Margin | 31.44% | 26.80% | 25.68% | 24.41% | 24.01% | 24.30% |
D&A For EBITDA | 513.53 | 265.1 | 227.9 | 132.7 | 95.5 | 116.1 |
EBIT | 1,049 | 996.7 | 792.1 | 646.8 | 548.3 | 372.9 |
EBIT Margin | 21.11% | 21.17% | 19.95% | 20.26% | 20.45% | 18.53% |
Effective Tax Rate | 24.82% | 25.11% | 22.70% | 25.53% | 25.26% | 25.41% |
Revenue as Reported | 5,039 | 4,767 | 4,022 | 3,243 | 2,697 | 2,025 |